Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2 Mercaptoethanesulfonate
2. 2-mercaptoethanesulfonate
3. 2-mercaptoethanesulphonate, Sodium
4. Asta D 7093
5. Asta-d 7093
6. Astad 7093
7. Coenzyme M
8. Ethanesulfonic Acid, 2-mercapto-, Monosodium Salt
9. Mesna Cell
10. Mesna-cell
11. Mesnex
12. Mesnum
13. Mistabron
14. Mistabronco
15. Mitexan
16. Mucofluid
17. Sodium 2-mercaptoethanesulphonate
18. Ucb 3983
19. Ucb-3983
20. Ucb3983
21. Uromitexan
22. Ziken
1. 19767-45-4
2. Sodium 2-mercaptoethanesulfonate
3. Uromitexan
4. Mesnex
5. Mitexan
6. Mistabron
7. Mesnum
8. 2-mercaptoethanesulfonic Acid Sodium Salt
9. Mistabronco
10. Sodium 2-mercaptoethane Sulfonate
11. Ethanesulfonic Acid, 2-mercapto-, Monosodium Salt
12. Coenzyme M Sodium Salt
13. Sodium;2-sulfanylethanesulfonate
14. 2-mercaptoethanesulfonate, Sodium
15. 2-mercaptoethanesulfonic Acid Sodium
16. Sodium 2-mercaptoethanesulfonate;mesnum
17. Sodium 2-sulfanylethane-1-sulfonate
18. D 7093
19. D-7093
20. Nr7o1405q9
21. Nsc-113891
22. Ncgc00181166-01
23. Dsstox_cid_809
24. Dsstox_rid_75800
25. Dsstox_gsid_20809
26. Mesnum [inn-latin]
27. Smr000059219
28. Cas-19767-45-4
29. Natrium 2-mercaptoethansulfonat
30. Ccris 3712
31. 2-mercaptoethane Sulfonate Sodium
32. Sodium 2-mercaptoethanesulphonate
33. Einecs 243-285-9
34. Nsc 113891
35. Unii-nr7o1405q9
36. 2-mercapto-ethan-sulfonsaeure, Natrium-salz
37. 2-mercaptoethanesulfonic Acid Monosodium Salt
38. Mesna [usan:usp:inn:ban]
39. Uromitexan (tn)
40. Sodium 2-mercaptoethane-1-sulfonate
41. Mesnex (tn)
42. Mfcd00007535
43. Prestwick_1005
44. Mesna [vandf]
45. Mesna [usan]
46. Spectrum2_000752
47. Spectrum3_001483
48. Spectrum4_000041
49. Spectrum5_001174
50. Mesna [inn]
51. Mesna [jan]
52. Mesna [who-dd]
53. Mesna [mart.]
54. Mesna [mi]
55. Mesna (jan/usp/inn)
56. Chembl975
57. Schembl7993
58. Mesna (uromitexan, Mesnex)
59. Mesna [orange Book]
60. Kbiogr_000501
61. Mesna [ep Monograph]
62. Mesna [usp Impurity]
63. Mls001074691
64. Mls001333251
65. Mls001333252
66. Mesna [usp Monograph]
67. Spectrum1502014
68. Sodium2-mercaptoethanesulfonate
69. Spbio_000764
70. Dtxsid1020809
71. Chebi:31824
72. Hms502f17
73. Kbio3_002565
74. Hms1921d10
75. Hms2092n09
76. Hms2236l05
77. Hms3259d13
78. Hms3372m11
79. Hms3655m06
80. Hms3715h05
81. Sodium, 2-mercapto-ethanesulfonate
82. Bcp14384
83. Tox21_112767
84. Tox21_200863
85. Bdbm50247978
86. Ccg-40134
87. S1735
88. Akos006220661
89. Akos015960755
90. Tox21_112767_1
91. Ac-6011
92. Cs-1364
93. Nc00648
94. Ncgc00094939-01
95. Ncgc00094939-02
96. Ncgc00178318-04
97. Ncgc00258417-01
98. Sodium 2-sulphanylethanesulphonate
99. 2-mercaptoethanesulphonic Acid Sodium Salt
100. As-13260
101. Hy-13679
102. Db-044962
103. A8469
104. M0913
105. Sw199618-2
106. En300-49858
107. D01459
108. Ab01274734-01
109. Q424997
110. W-60283
111. Q-201713
112. 3-aminooxy-n-propyl(dimethyl-t-butylsilyl)ether
113. Z1741968275
Molecular Weight | 164.18 g/mol |
---|---|
Molecular Formula | C2H5NaO3S2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 163.95778065 g/mol |
Monoisotopic Mass | 163.95778065 g/mol |
Topological Polar Surface Area | 66.6 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 123 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Mesna |
PubMed Health | Mesna |
Drug Classes | Hemorrhagic Cystitis Inhibitor |
Drug Label | Mesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide. The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a molecu... |
Active Ingredient | Mesna |
Dosage Form | Injectable |
Route | injection; Intravenous |
Strength | 1g/10ml; 100mg/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Fresenius Kabi Usa; Mylan Institutional; Sagent Pharms; Eurohlth Intl; Agila Speclts |
2 of 4 | |
---|---|
Drug Name | Mesnex |
PubMed Health | Mesna (By mouth) |
Drug Classes | Hemorrhagic Cystitis Inhibitor |
Drug Label | Mesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide (IFEX). The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a... |
Active Ingredient | Mesna |
Dosage Form | Tablet; Injectable |
Route | Oral; Intravenous |
Strength | 400mg; 100mg/ml |
Market Status | Prescription |
Company | Baxter Hlthcare |
3 of 4 | |
---|---|
Drug Name | Mesna |
PubMed Health | Mesna |
Drug Classes | Hemorrhagic Cystitis Inhibitor |
Drug Label | Mesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide. The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a molecu... |
Active Ingredient | Mesna |
Dosage Form | Injectable |
Route | injection; Intravenous |
Strength | 1g/10ml; 100mg/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Fresenius Kabi Usa; Mylan Institutional; Sagent Pharms; Eurohlth Intl; Agila Speclts |
4 of 4 | |
---|---|
Drug Name | Mesnex |
PubMed Health | Mesna (By mouth) |
Drug Classes | Hemorrhagic Cystitis Inhibitor |
Drug Label | Mesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide (IFEX). The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a... |
Active Ingredient | Mesna |
Dosage Form | Tablet; Injectable |
Route | Oral; Intravenous |
Strength | 400mg; 100mg/ml |
Market Status | Prescription |
Company | Baxter Hlthcare |
Protective Agents
Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. (See all compounds classified as Protective Agents.)
R - Respiratory system
R05 - Cough and cold preparations
R05C - Expectorants, excl. combinations with cough suppressants
R05CB - Mucolytics
R05CB05 - Mesna
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AF - Detoxifying agents for antineoplastic treatment
V03AF01 - Mesna
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-15
Pay. Date : 2013-12-24
DMF Number : 22664
Submission : 2009-03-23
Status : Active
Type : II
Certificate Number : R1-CEP 2009-127 - Rev 01
Issue Date : 2022-11-30
Type : Chemical
Substance Number : 1674
Status : Valid
Date of Issue : 2023-01-06
Valid Till : 2025-07-29
Written Confirmation Number : WC-0099
Address of the Firm :
NDC Package Code : 15308-0715
Start Marketing Date : 2002-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-12-27
Pay. Date : 2012-11-15
DMF Number : 16255
Submission : 2002-11-15
Status : Active
Type : II
NDC Package Code : 58623-0039
Start Marketing Date : 2010-04-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-01
Pay. Date : 2015-09-08
DMF Number : 29522
Submission : 2015-06-29
Status : Active
Type : II
Certificate Number : CEP 2015-299 - Rev 01
Issue Date : 2024-08-20
Type : Chemical
Substance Number : 1674
Status : Valid
Date of Issue : 2021-08-06
Valid Till : 2024-03-04
Written Confirmation Number : WC-0294
Address of the Firm :
NDC Package Code : 72643-007
Start Marketing Date : 2015-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25276
Submission : 2011-09-08
Status : Active
Type : II
Registration Number : 223MF10085
Registrant's Address : Edisonstrasse 4,85716 Unterschleissheim, Germany
Initial Date of Registration : 2011-06-17
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14732
Submission : 2000-02-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26037
Submission : 2012-05-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3880
Submission : 1980-06-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12072
Submission : 1996-08-05
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?